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INTRODUCTION
Proteolytic enzymes are extensively distributed in all types of organisms; 2% of all
gene products are peptidases [1]. They catalyze the cleavage of the peptide bond.
Depending on the cleavage site they can be divided into proteases which remove
terminal residues and  proteinases which act on peptide bonds in the inner polypeptide
chain. Proteolytic enzymes can be assigned to four distinct groups on the basis of their
catalytic types: serine, cysteine, aspartic and metallo proteinases [2]. The names of the
enzyme groups refer to the components of their active site.
Cysteine proteinases are a large group including lysosomal cathepsins.
Physiologically cysteine proteinases have an important role in protein metabolism and
turnover. In addition, processing and activation of many prohormones, proenzymes
and peptides is conducted by cysteine proteinases.
The action of cysteine proteinases can be regulated and inhibited by endogenous,
natural inhibitors as well as by compartmentalization and surrounding conditions e.g.
pH or chelating agents. If this well-balanced control system is disturbed it can lead to
serious damage. Many pathogens have their own cysteine proteinases to invade hosts.
Disturbed expression of cysteine proteinases and their natural inhibitors is associated
with some pathological conditions like arthritis, neurological disorders and cancer.
The interactions between cysteine proteinases and their inhibitors have been a target
of intensive studying for the last two decades. The specific inhibitors of cysteine
proteinases are needed in preventing unwanted, potentially destructive proteolysis; they
can be utilized in therapy and in research [3]. A deeper understanding of these
interactions may give us the means to control the proteolytic activities. New structural
data also adds information about the evolution of both cysteine proteinases and their
protein inhibitors as well as about the species studied.
The endogenous inhibitors of cysteine proteinases, cystatins, are reported to act
as defensive agents against bacteria, viruses and pests. One of the first cystatins was
discovered from the rat skin [4] and soon after that from human skin [5]. As fishes
live in pathogen-rich environments, it is possible that their skin too contains this non-
specific form of defence mechanism.
The present study characterizes high molecular weight cysteine proteinase
inhibitors isolated from the skins of some salmonid and non-salmonid fish species.
ii
11. REVIEW OF THE LITERATURE
1.1. Cysteine proteinases
The cysteine proteinase superfamily consists of about 20 families which are grouped into
six clans (CA, CB, …, CF) [1]. All cysteine proteinases have a similar catalytic mechanism
where cysteine and histidine residues are located in the active centre [6]. Their classification
is based on the order of the catalytic residues (His/Cys or Cys/His) and other structural
features, but it is likely to change as more structural data becomes available [6]. The most
studied family is papain-like cysteine proteinases grouped into clan CA with catalytic
residues Cys-25 and His-159 (papain numbering) [1]. In this clan there are enzymes
from all organisms; animals (cathepsins, calpain), plants (papain, ficin), protozoa
(cruzipain), bacteria (streptopain) and viruses (V-cath proteinase) [1]. Comprehensive
information about different types of proteinases can be found in the MEROPS database [7,8].
Cysteine proteinases of the papain family are either secreted or lysosomal enzymes.
In plants they are located in vacuoles and in secreted fluids like the latex of papaya. They
are synthesized as inactive zymogens with signal peptides and with an N-terminal (usu-
ally glycosylated) propeptide region [6]. The proregion is needed for proper folding, sta-
bility and transport of the enzyme [9]. It also inhibits proteolytic activity until the enzyme
is needed. Thus, cleavage of the propeptide is essential for activation of the enzyme [6, 10].
The most widely characterized enzymes in papain-like cysteine proteinase family are
cathepsins [reviewed in 1, 11, 12]. On the basis of their propeptides papain-like cysteine
proteinases can be divided into two subfamilies. Cathepsin L -like enzymes have a 100
amino acid long propeptide with the interspersed amino acid motif ERFNIN [10, 13].
This motif is not found in cathepsin B -like enzymes which have shorter propeptides (60
amino acids) (Figure 1). [9, 10].
In mammals the major function of cysteine proteinases is lysosomal protein
degradation and specific protein processing [10], but they also have a role in cancer [14],
Figure 1. A picture of the structural properties of two types of cathepsins belonging to the papain
family.  Human cathepsin L (P07711) has a 96 amino acid long propeptide region (gray box)
with the conserved interspersed motif ERFNIN. The mature cathepsin L consists of a heavy
chain (hatched box) and a light chain (squared box) connected with a disulfide bridge. Human
cathepsin B (P07858) has a 62 amino acid long propeptide region. The mature cathepsin B con-
sists likewise of heavy chain and light chain connected with a disulfide bridge. Both cathepsins
have a short signal sequence  (white box) in their N-terminus.
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2antigen processing [15], arthritis [16], Alzheimer’s disease, muscular disorders and
gingivitis [17]. Several cysteine proteinases of pathogen origin have also been characterized
in great detail: histolysin and amoebapain of Entamoeba histolytica, aid the amebiasis
infection and invasion by proteolytic actions [18], cruzipain, a cysteine proteinase of
Trypanosoma cruzi causing Chagas disease [19] and falcipain , a malarial haemoglobinase
of Plasmodium falciparum [1]. The regulation of destructive proteolysis could prevent
pathogen invasion and severe tissue damage in disease.
1.1.1. Regulation of cysteine proteinases
The biological activity of cysteine proteinases is regulated by inhibitors, pH and zymogen
activation [20]. Non-specific inhibitors of peptidases in general are ±-macroglobulins,
which bind and inhibit irreversibly most proteinases; peptide aldehydes (leupeptin and
antipain) acting as reversible transition-state analogues and peptide chloromethyl ketones
which inactivate proteinases by binding the inhibitor and alkylating the active site [21].
Peptide diazomethanes and peptide epoxides alkylate active-site cysteine inhibiting
particularly cysteine proteinases but they can not discriminate between different cysteine
proteinases [21]. New synthetic cysteine proteinase inhibitors are under research [22].
Natural endogenous inhibitors include proregions of proteinases and inhibitory molecules
with protein structure such as cystatins (see below).
All papain-like cysteine proteinases are synthesized as inactive proenzymes,
zymogens. The proregion is needed for proper folding and transport of newly synthesized
enzyme [10]. Cathepsins are transported from the Golgi apparatus to the lysosomes where
the pH is acidic [10]. This acidic environment has two functions. It triggers the proteolytic
cleavage of propeptide yielding mature cathepsin [23] and provides the optimum pH for
these enzymes to function [24]. A neutral pH as well too acidic pH rapidly inactivates
cathepsins [25]. Further, one mechanism of regulation is that cathepsins are stable only
in a certain pH range which differs for every cathepsin. Throughout the maturation the
pH declines in lysosomes. Therefore different cathepsins are activated at different
maturation stages of lysosomes [26]. In mature lysosomes pH can reach values as low as
3.8 which is sufficiently low to cause irreversible denaturation of cathepsins B, S and L
[11].
1.1.2. Cysteine proteinases in fish
Elevated levels of cathepsins B, D, H and L have been reported in the white muscle of
chum salmon (Oncorhynchus keta) in spawning migration [27]. Cathepsin L [28] and
cathepsin B [29] have been purified and characterized from the chum salmon. One kind
of cysteine proteinase, miltpain, is found in the milt of both chum salmon [30] and Pacific
cod [31]. The determined N-terminal sequences (17 amino acid residues) for miltpains
are not similar to each other and neither do they show any significant homology to any
other proteins in the databases. However, both miltpains share other properties like
substrate specificity towards paired basic residues. These results suggest that miltpain is
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3a new type of cysteine proteinase [31]. Preliminary studies have also been made on Mujil
auratus cathepsin B [32, 33] and arrowtooth flounder (Atheresthes stomias) cathepsin L
[34, 35].
In the GenBank there is a gene sequence (accession number AF281331) from rainbow
trout encoding a protein which was submitted as a cathepsin. The gene is found by a
method where a pool of clones were sequenced (suppression subtractive hybridization)
and then analysed with the BLASTX program. The most likely hit for this gene was
cathepsin which was given as identification for the new sequence and the result was not
verified [36], as discussed in more detail in the discussion section.
Salmons cease feeding in fresh water before spawning [37], hence the cathepsins are
probably needed at this stage to degrade proteins as a source of energy.  Autolysis of
mature chum salmon muscle has been shown to be caused by cathepsins [38]. Similar
observations have also been made for hake (Merluccius hubbsi) where autolysis in muscle
takes place even after frozen storage [39]. Both chum salmon and hake are alimentary
fish, so their muscle autolysis deteriorates the quality of their fillets.
 Epidermal proteinases may play a role in the natural immunity of fish. This non-
specific defence mechanism has been studied in different eel species [40] and in Japanese
flounder [41]. In these species cathepsins B and L have been suggested to act as
antibacterial agents. Our collaborator group purified cathepsins B, L, D and H from
Atlantic salmon (manuscript in preparation). The results of their immunohistochemical
localization studies show that cathepsins B and L are localized mainly in lysosomal-like
vesicles of the kidney and liver and also in potential antigen presenting cells in
immunologically important organs [42].
1.2. Cysteine proteinase inhibitors
1.2.1. The cystatin superfamily
The first inhibitor of papain was reported from chicken egg white in 1968 [43]. When
this protein was further characterized it was named cystatin [44], being the first member
of the cystatin superfamily. Other cysteine proteinase inhibitors were reported
independently in several laboratories during the 70-80’s [45, 46, 47, 48, 49] thus forming
the basis for the cystatin superfamily. The nomenclature and classification of cysteine
proteinase inhibitors was decided at the First International Symposium on Cysteine
Proteinases and their Inhibitors in 1985 [50].  The cystatin superfamily is divided into
three structurally related families: stefins, cystatins and kininogens. It has been proposed
that one of their functions is to defend the host against pathogens and parasites [51].
The evolutionary relationships of cystatins were studied on the basis of sequence
homology. One model suggests that there has been one archetypal unit which has evolved
into four families according to sequence similarity and biological function [52]. Another
study proposes that cystatins have evolved from two units: A and B [53]. In this model
stefins are made only from unit A thus forming the archetype of the superfamily. Cystatins
have units A and B with disulphide bonds whereas kininogens have arisen from gene
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3
. Both models, however, leave a missing link between
cystatins and kininogens, consisting of two AB units [53]. A schematic drawing of cystatin
structures is presented in Figure 2. According to all the models a distinct feature of cystatin
is the amino acid sequence QVVAG.
Also, on a structural basis fetuins, histidine-rich glycoprotein and other cystatin-
related proteins, with no inhibitory activity, could be included in the cystatin superfamily
[54]. Cystatins of plant origin (phytocystatins) differ slightly from cystatins and stefins
by having a consensus sequence LARFADEHN which is absent from other cystatins
[55]. Therefore the phytocystatins could be classified as a distinct family in the cystatin
superfamily.
Also, completely new types of cysteine proteinase inhibitors have emerged. Our
recent comprehension [56] is further expanding the cystatin superfamily into three different
groups: The first group are sensu stricto cystatins, structurally related proteins inhibiting
cysteine proteinases. The second group has a structural similarity to conventional cystatins
but no inhibitory activity, like fetuins. The third group are cysteine proteinase inhibitors
which share no structural homology with group 1, like chagasin [56]. Table 1 presents
this classification with some examples. The protease database MEROPS [8] has its own
classification system for all types of protease inhibitors.
Figure 2. A schematic picture of protein structure in cystatin superfamily. Unit A is archetypal
cystatin and contains conserved QVVAG sequence. Unit B has two disulfide bonds. The heavy
chain of kininogen consists of three cystatin domains (AB)
3
and the light chain of kininogen can
be shorter or longer thus determining LMW or HMW kininogen.
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51.2.1.1. Cystatin family 1. Stefins
Stefins are single-chain proteins with neither disulphide bonds nor carbohydrates (Fig
1). Their molecular weight is about 11 kDa. Stefins are localized mainly intracellularly
but have been found also in extracellular fluids [26]. The nomenclature of stefins can be
confusing because they are also called cystatins e.g. cystatin A means stefin A [51, 57].
The cystatins of human [5], rat [46] and bovine [58,59] origin have been reported. This
group is considered to be similar to archetypal cystatins [52, 53].
1.2.1.2. Cystatin family 2. Cystatins
Cystatins contain two characteristic disulfide bonds near their C-terminus (Fig 1). Their
molecular weight is a bit higher than that of stefins, about 13 kDa [56]. Usually they
occur in secretions like chicken egg-white and other fluids including blood plasma [51].
Cystatins are non-glycosylated with the exception of the rat cystatin C [56]. Some cystatins
are also phosphorylated, but this phosphorylation does not effect their inhibitory activity
[60, 61].
1.2.1.3. Cystatin family 3. Kininogens
Kininogens consist of an N-terminal heavy chain combined with a bradykinin sequence
to a variable length light chain (Fig 1). The heavy chain has three cystatin-like domains
Table 1. Classification of cystatins and other cysteine proteinase inhibitors and examples of
them in human and fish.
________________________________________________________________________________
Group I Traditional cystatin superfamily
- 1. Stefins Stefin A
- 2. Cystatins Cystatin C chum salmon 
cystatin C
- 3. Kininogens HMW Kininogen Salmon kininogen
- 4. Phytocystatins - -
Group II Structurally cystatin-like molecules with no inhibitory activity
Histidine rich glycoprotein (HRG) human HRG
Fetuins human fetuin zebrafish fetuin
Group III Cysteine proteinase inhibitors with no structural homology to group I
Thyropins equistatin chum salmon 
inhibitor
Cathepsin L proregion-like - salarin
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6and the length of the light chain determines whether the kininogen is a high molecular
weight kininogen (HMW kininogen, 120 kDa) or a low molecular weight kininogen (LMW
kininogen, 68 kDa) [56]. Bradykinin is a conserved vasoactive peptide controlling the
action of smooth muscle cells. Three types of kininogens are known: HMW, LMW and T-
kininogen (only in rat), most of them being sialyl-glycosylated [51]. Kininogens have
many different functions in the blood coagulation cascade, muscle contraction, acute
phase response and inhibition of cysteine proteinase [62]. Some of these functions are
mediated by bradykinin. Bradykinin can be released by the action of kallikrein leaving
the N-terminal heavy chain and the C-terminal light chain connected by a single disulfide
bridge [62].
The second domain of kininogens is known also to inhibit calpain, although other
cystatins are not effective against this enzyme [63].
1.2.2. Other types of cysteine proteinase inhibitors
The first larger group of other cystatins are thyropins (thyroglobulin type-1 proteinase
inhibitors) which are inhibitors of cysteine proteinases containing at least one thyroglobulin
type-1 domain [64]. Equistatin from sea anemone inhibits cysteine proteinases and is
structurally similar to thyroglobulin type-1 [65]. It also inhibits cathepsin D which is an
aspartic proteinase [66] whereas traditional cystatins do not inhibit other classes of
proteinases. Saxiphilin is an inhibitor of papain-like cysteine proteinases isolated from
bullfrog. It has two thyroglobulin type-1 domains [67].
One thyropin has also been isolated from the eggs of chum salmon (see below) [68].
Clitocybin (P82314) is a new type of cysteine proteinase inhibitor from a mushroom.
Clitocybin appears to be related to fungal lectins and the team that found it suggested a
new family of cysteine proteinase inhibitors called mycocypins [69]. Chagasin (Q966X9)
is a cysteine proteinase inhibitor found in Trypanozoma cruzi inhibiting both cruzipain
and papain, but it has no homology with cystatins or with other published sequences in
the databanks [70].
Proregions of cysteine proteinases are known to selectively inhibit their cognate
enzymes. There are studies on mammalian proteinases as cathepsin B [71], cathepsin L
[72] and cathepsins K, L and S [73] which are selectively inhibited by their respective
recombinant or synthetic propeptides. Also trypanosomal cysteine proteinases congopain
and cruzipain are inhibited by their propeptides but not by cathepsin propeptides [74].
A novel inhibitor protein from the silkmoth Bombyx mori is homologous to propeptide
regions of cysteine proteinases [75]. Other propeptide-like inhibitors are CTLA-2 [76]
and Drosophila CTLA-2-like protein [77]. These findings suggest that propeptide regions
inhibiting cysteine proteinases have evolved as autonomous elements. As shown in our
studies (I, IV) also a cysteine proteinase inhibitor from the skin of Atlantic salmon has
structural similarity with propeptide regions of cathepsins.
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71.2.3. Cysteine proteinase inhibitors in fish
A cysteine proteinase inhibitor was described from a fish for the first time in 1988 [78].
The 50 kDa inhibitor was isolated from the muscle of carp and it was shown to inhibit
both papain and calpain [78]. No structural data or other evidence of the family of this
carp inhibitor was presented, but it may have been kininogen, based on the molecular
weight and the fact that kininogens inhibit calpains unlike the other cystatins [63].
Both the proteinases and their inhibitors have been intensively studied in chum salmon
(Oncorhynchus keta). A thyroglobulin-like cysteine proteinase inhibitor has been found
in the eggs of chum salmon [68, 79]. Also, cystatin is found in the muscle of chum
salmon [80]. A cystatin homologous to mammalian cystatin C was first isolated and
sequenced from the pituitary gland of chum salmon [81] and later cloned and expressed
[82]. Cystatin C is reported also to exist in rainbow trout [83, 84]. Cystatin has also been
found from carp [85], fugu [86] and zebrafish [87]. These inhibitors are low molecular
weight cystatins.
A preliminary report of high molecular weight cysteine proteinase inhibitors in
Atlantic salmon (Salmo salar L.) appeared in 1998 [88]. As these results were partly
erroneous the study was continued leading to publications I, II, III and IV.
There have been no other reports describing fish kininogens prior to our publications.
However, earlier fish bradykinin findings imply that kininogens exist in fishes too.
Bradykinin had been found from the plasma of steelhead trout [89], bowfin [90] and
Atlantic cod [91]. Also, the sarcopterygian lungfish has bradykinin [92].These results
were obtained by incubating fish plasma with kallikrein or trypsin and the peptides were
sequenced and compared with mammalian bradykinin.
In addition to the carp inhibitor [78] the only high molecular weight cysteine
proteinase inhibitor from fish has been thyropin from chum salmon [79]. No reports of
proteinase proregion -like cysteine proteinase inhibitors in fish have been observed.
1.3. Glycosylation of proteins
1.3.1. Protein glycosylation in general
Glycosylation is perhaps the most important post-translational modification of proteins.
It is needed for proper folding and stabilization of proteins [93]. Some glycan structures
are crucial either for the function or the proper location of proteins.
The N-glycosylation of proteins is an essential part in the quality control of
polypeptide folding in endoplasmic reticulum [94]. Targeting of lysosomal enzymes is
mediated by the specific glycan structure, phosphomannosyl marker, which is recognized
by mannose-6-phosphate receptor in P-type lectins [95]. Glycan structures are also involved
in many important recognition events, for example adhesion of leukocytes to endothelial
cells by L-selectin [96]. Important as it is the glycosylation of proteins is not crucial on
all occasions. There are enzymes which function normally after deglycosylation [97] and
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8some experiments show that recombinant proteins without their glycan part function
properly [98]. However, in vivo their transport would be impaired.
Vertebrates have two main types of oligosaccharides; N-linked and O-linked. N-linked
glycans are linked to the asparagine residue of a polypeptide chain in the consensus sequence
Asn-X-Thr/Ser. O-linked glycans are linked to serine or threonine residues in the polypeptide
chain. Figure 3 summarizes the most common structures of N- and O-glycans. [99].
Glycans can be modified in several ways to yield an extended complexity. Many of
the explanations for complex glycan structures are not yet understood [100].
The terminal part of many glycans is sialic acid. The elementary units of sialic acids
are N-acetylneuraminic acid (NeuNAc), N-glycolylneuraminic acid (Neu5Gc) and 2-
Figure 3. Examples of common structures of vertebrate N– and O-linked glycans.
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9keto-3-deoxy-nonulosonic acid (KDN) [101]. Sialic acids can be modified in many ways
and over 40 modifications are known [102]. One of the most common modification is O-
acetylation [102]. O-acetyl-groups can be attached to positions 7, 8, 9 and 4 of the sialic
acid [101]. The function of O-acetylation is not completely understood but at least it has
a protective function, as many sialic acid hydrolyzing enzymes (sialidases) are inhibited
by O-acetylation [102]. It also inhibits the binding of certain viruses, but on the other
hand O-acetylated sialic acids are also receptors for certain other viruses [101].
1.3.2. Glycosylation in fish proteins
The best characterised fish glycans originate from fish egg glycoproteins. Rainbow trout
(Oncorhynchus mykiss) eggs were the second source where disialosyl groups were
described on a glycoprotein [103], this structure had previously been shown to exist in rat
brain [104, 105]. Several salmonid species were then reported to have even tetrasialylated
O-glycans on their egg glycoproteins [106]. These proteins were named
polysialoglycoproteins (PSGP) and even 50% of their weight consists of sialic acids
[106]. O-acetylated sialic acid residues of PSGPs have been reported as well [107]. Fish
eggs also have small glycophosphoproteins with sialylated N-glycans. Furthermore these
glycans are found in the free form and they seem to be species specific [108]. Hyosophorin
from the unfertilized eggs of dace (Tribolodon hakonensis) contain highly sulphated
multiantennary N-glycans [109]. Rainbow trout ovarian fluid has tetra-antennary α2,3-
disialylated poly-N-lactosamine chains with Lex and I antigens as terminal parts [110].
Antifreeze glycoproteins (AGFP) in polar fish have also been widely studied [111].
The most common glycan structure in AFGPs is Gal²1,3GalNac, but the essential
components for antifreeze activity have not been determined [112].
Atlantic salmon antithrombin has only three carbohydrate chains [113] whereas human
antithrombin contains four carbohydrate chains. Interestingly, albumin from brown trout
(Salmo trutta) is reported to be glycosylated but the albumin from Chinook salmon
(Oncorhynchus tshawytscha) is not. As albumin in mammals is not glycosylated it is
possible that the ancestral albumin was glycosylated [114]. Very few detailed structural
studies on fish glycans are available.
1.4. Fish species
More than half of living vertebrate species are fishes. The systematic classification of
fishes is largely based on anatomical investigations. Based on anatomical criteria the
Atlantic salmon is classified as a rather primitive fish, Atlantic cod is more advanced and
the spotted wolf fish is the most advanced of the three species. [115].
The Atlantic salmon (Salmo salar L.) is popular both as gamefish and in aquaculture.
It is native in both the west and east Atlantic. It is anadromous species, which means that
is lives in fresh water for the first 2-3 years before it migrates to sea. Smolts migrate to
sea for 1-2 years before they return to fresh water to spawn. Before spawning they stop
Review of the Literature
10
eating. One difference between the Atlantic and Pacific salmon is that Pacific salmon
dies soon after spawning. The subfamily Salmoninae contains seven genera including
Salmo, Salvelinus and Oncorhynchus. [115, 37].
Atlantic cod (Gadus morhua) is a popular gamefish as well as important market
fish. It can grow to nearly 2 m long and is omnivorous. Cod lives at bottom of the sea and
its scales are covered with epidermis. Recently, the farming of cod has been under research
and development. [116, 117].
The spotted wolf fish (Anarchichas minor) inhabits the North Atlantic and Barents
Sea. It is found mainly in cold and deep waters.  Sharp-teethed wolf fishes are popular
gamefish and food. The farming of the wolf fish is under research and development. It is
very resistant to most diseases and it has a leatherlike skin which can be used for clothes.
[115, 117].
The nomenclature of fish species mentioned in this study can be found in Table 2.
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Table 2. Fish names and classification according to Ref. 37.
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Class Osteichthyes Luukalat
Order Anguilliformes Ankeriaskalat
Japanese eel Anguilla japonica Japanin ankerias
Order Salmoniformes Lohikalat
Atlantic salmon Salmo salar lohi
Arctic charr Salvelinus alpinus nieriä
Chum salmon Oncorhynchus keta koiralohi
Rainbow trout Oncorhynchus mykiss kirjolohi
Sockeye salmon Oncorhynchus nerka punalohi
Order Gadiformes Turskakalat
Atlantic cod Gadus morhua turska
Pacific cod Gadus macrocephalus Tyynenmeren turska
Hake Merluccius hubbsi Marini kummeliturska
Order Cypriniformes Karppikalat
Carp Cyprinus carpio karppi
Dace Tribolodon hakonensis seipi
Zebrafish Danio rerio seeprakala
Order Perciformes Ahvenkalat
Spotted wolf fish Anarhichas minor täplikäs merikissa
Mujil auratus mullo
Order Pleuronectiformes Kampelakalat
Turbot Scophthalmus maximus piikkikampela
Order Tetraodontiformes Jäykkäleukakalat
Fugu Fugu rubribes pallokala
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2. AIMS OF THE STUDY
This study was started as a part of EU-project CT97-3508 “Fish cysteine proteinase
inhibitors and infectious diseases”. The objective of this study was to purify high molecular
weight cysteine proteinase inhibitors from the skin of Atlantic salmon, Atlantic cod and
spotted wolf fish for structural studies. It was suggested that the inhibitors might have a
role in defence mechanisms of fish against pathogens. Therefore the purified inhibitors
were biologically tested by other partners of the project. During the project the specific
aims were formulated as:
• development of a purification method generally applicable for these inhibitor
proteins
• structural and functional characterization of the  proteins
• glycan analysis of the proteins
• cloning and sequencing of the gene of the previously unknown protein salarin.
Aims of the Study
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3. MATERIALS AND METHODS
3.1. Fish materials
Fishes were obtained from Aquaculture station of Norwegian College of Fishery Science
at Kårvika, Tromsø, Norway, except for the rainbow trout which was purchased from fish
market in Finland.
Skin extracts from Atlantic salmon (Salmo salar L.), Arctic charr (Salvelinus alpinus
L.), Atlantic cod (Gadus morhua L.), spotted wolf fish (Anarhichas minor Olafsen),
rainbow trout (Oncorhynchus mykiss Walbaum) and turbot (Scophthalmus maximus) were
used as the source for protein extraction. The skin (1 kg) was homogenized with Waring-
Blender type homogenizer in 1 l of 10 mM Tris/HCl pH 7.4, 10 mM EDTA, 0.25 M
sucrose, 0.1 mM phenylmethanesulfonyl fluoride, 5 mM benzamidine and 15 mM sodium
azide. The homogenate was centrifuged at 6000 g for 30 min at 4 °C and the supernatant
was collected. The supernatant was ultracentrifuged at 100 000 g for 2 h at 4 °C and the
clear extract was collected underneath the floating fat. Skin extracts were kept in -20 °C
until used.
Liver and skin from Atlantic salmon (Salmo salar L.), liver from Arctic charr and
liver from spotted wolf fish (Anarhichas minor Olafsen) were used for RNA and DNA
isolation. Organs were collected from freshly killed animals, frozen with liquid nitrogen
and kept in -70 ºC until used.
3.2. Purification and characterization of the inhibitors
3.2.1. Chromatographic methods
A four-step purification scheme was developed for the purification of cysteine proteinase
inhibitors from the fish skin extracts. Affinity chromatography of the inhibitors was
performed by carboxymethyl-papain-Sepharose 4B (Pharmacia Biotech, Uppsala, Sweden)
[118]. The affinity chromatography column was equilibrated with 20 mM sodium
phosphate, pH 7,5 at a flow rate of 0.5 ml/min and the clear skin extract was applied to
the column. The column was then washed with 2 column volumes of equilibration buffer
and the non-specifically bound proteins were removed by washing with 1 column volume
of the 1 M NaCl in equilibration buffer. Then the column was washed again with one
column volume of the equilibration buffer and the bound proteins were finally eluted
with 20 mM sodium phosphate, pH 11.8, 0.1 M NaCl, monitoring at 280 nm.
The inhibitory activity of the eluted fractions was determined by inhibition assay
(see below) and the fractions expressing the inhibitory activity were pooled and
concentrated with pressure microfiltration (Omegacell 10 K, Pall Filtron, Northborough,
MA, USA). The concentrate (500 µl) was subjected to gel filtration on a Superdex 200
HR10/30 column (Pharmacia Biotech) equilibrated with 50 mM Tris/HCl pH 8.0, 300
mM NaCl at a flow rate of 0.5 ml/min. The gel filtration was monitored at 280 nm and
the eluted fractions with inhibitory activity were pooled and diluted with water (1:1)
Materials and Methods
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before anion-exchange chromatography. Anion-exchange chromatography was performed
on a Mono Q HR 5/5 column (Pharmacia Biotech). The column was equilibrated with 50
mM Tris/HCl pH 8.0 and elution was performed with a linear salt gradient (0-0.5 M
NaCl in 40 min) at a flow rate of 1.0 ml/min in the equilibration buffer and monitored at
280 nm.
Reversed-phase chromatography was performed at a flow rate of 1.0 ml/min on 0.46
x 4 cm, TSK TMS 250 (C1, TosoHaas Corporation, Japan) column equilibrated with 0.1
% trifluoroacetid acid. Elution was performed with a linear gradient of acetonitrile (15-
60 % in 60 min) in 0.1 % trifluoroacetic acid and monitored at 214 nm. Analytical reversed-
phase chromatography for purity and quantity estimations of proteins was performed as
above but on a 0.21 x 10 cm TSK TMS 250 a column using a flow rate of 0.2 ml/min.
3.2.2. Inhibition assay
The inhibitory activity of chromatographic fractions was determined by inhibition assay
with papain as an enzyme and BANA (N
α
-benzoyl-DL-arginine-2-naphtylamide, Fluka
Chemie AG, Buchs, Switzerland) as a substrate. 25 µl of papain solution (0.3 mg/ml,
Sigma, St Louis, MO, USA) was incubated with 25 µl of chromatographic fractions (as
the inhibitor) in 25 µl of assay buffer (0.2 M Tris/HCl pH 7.6, 8 mM EDTA, 4mM
dithiotreitol) in a 96 well microtiter plate (Falcon, Becton-Dickinson) at room temperature
for 10 min. Then 25 µl of BANA solution (5mM in 20 % methanol) was added and
incubation continued for 10 min at 37 °C. The reaction was stopped by adding 100 µl of
dimethylamino-benzaldehyde- reagent (500 mg 4-(dimethylamino)-benzaldehyde
(Merck)) dissolved in 50 ml methanol and 50 ml 1 M Na-acetate pH 1.4). After 30 min at
room temperature the developed colour was measured at 450 nm with a microwell reader
(Multiskan® MCC/340, Labsystems, Espoo, Finland).
The inhibitory activity was defined as follows. The activity of non-inhibited papain
(incubated without any inhibitors) was taken as 100 % activity and the activity of partially
inhibited papain (incubated with the inhibitory fractions) was expressed relative to 100
% activity calculated comparing the absorbances of their reaction mixtures. Thus when
the absorbance of the reaction mixture with non-inhibited papain was 0,899 and absorbance
of the reaction mixture with papain and the inhibitor was 0,237, the inhibitory activity
was calculated from the formula (0.899-0.237) / 0.899 * 100 = 73,6  so giving the inhibitory
activity as 73.6 % meaning that 73.6 % of papain activity is inhibited.
All assays were made in duplicates and an established proteinase inhibitor leupeptin
in serial dilutions was used as a control. This method is adapted from [46]. The inhibitory
activity of the purified fish inhibitors was also tested by the same method using ficin,
bromelain and trypsin as the proteinase.
3.2.3. SDS/PAGE and N-terminal sequencing
The purified proteins were separated by SDS/PAGE in 12 % gel and stained with
Coomassie Brilliant Blue or with silver stain [119].
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Protein and peptide sequencing was performed using a Procise 494 A sequencer.
For N-terminal sequence analysis the proteins were electroblotted from a SDS/PAGE
gel on to a PVDF (polyvinylidene difluoride membrane ProBlott™, Perkin-Elmer Applied
Biosystems Division) in 10 mM CAPS [3-(cyclohexylamino)propane-1-sulphonic acid
(pH 11)/10 % (v/v) methanol] as described [120]. After staining with Coomassie Brilliant
Blue (0.1 % in 1 % acetic acid/40 % methanol) the protein bands were cut out and loaded
on the sequencer. Alternatively, purified proteins were directly adsorbed to the
polyvinylidene difluoride membrane of a ProSorb™ (Perkin-Elmer, Applied Biosystems
Division) device and loaded to the sequencer.
Purified peptides were sequenced on a glass fiber disc pretreated with 1.5 mg
BioBrene™ (Perkin Elmer, Applied Biosystems Division, Foster City, CA, USA).
3.2.4. Enzymatic digestions and peptide separation
For in-gel digestion the proteins were separated by SDS/PAGE and stained with Coomassie
Brilliant Blue (0.1 % in 0.5 % acetic acid/30 % methanol) and destained (30 % methanol).
The proteins in the excised bands were alkylated with iodoacetamide and digested with
trypsin (Sequencing Grade Modified Trypsin, Promega Corporation, Madison, WI, USA)
or endoproteinase LysC (Wako Chemicals GmbH, Germany) as described [121]. For in-
solution digestion the purified proteins were alkylated with 4-vinylpyridine and digested
with trypsin or endoproteinase GluC (Sequencing Grade Endoproteinase GluC, Promega).
For endoproteinase GluC digestion a 30 µg sample of alkylated protein was dissolved in
50 µl of 50 mM ammonium acetate, pH 4.3 and digested with 0.5 µg of the enzyme by
incubation at 37 °C overnight [III]. Peptides were separated by narrow bore reversed-
phase chromatography on a 0.1 x 15 cm Vydac C8 column (300 Å, 5 µm, LC-Packings,
The Netherlands) using a SMART™ System (Pharmacia Biotech, Uppsala, Sweden).
Elution was performed using linear gradients of acetonitrile (0-40% in 120 min, 40-100
% in 40 min) in 0.1% trifluoroacetic acid. The flow rate was 50 µl/min, chromatography
was monitored at 214 nm and the peptides were collected automatically.
3.2.5. Mass spectrometry of proteins and peptides
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI
TOF MS) was performed in the positive-ion mode with a BIFLEX™ mass spectrometer
(Bruker Daltonik, Bremen, Germany), equipped a 337 nm nitrogen laser. Protein samples
were analysed in sinapic acid (Fluka) as the matrix as described [122]. Peptide samples
were analysed by mixing 1 µl of sample with 1 µl of α-cyano-4-hydroxy-cinnamic acid
matrix (saturated solution in 30 % acetonitrile, 0.1 % aqueous trifluoroacetic acid) and
dried with a stream of air. External calibration was performed with angiotensin II (Sigma,
A9525) and ACTH (adrenocorticotropic hormone) fragment 18-39 (Sigma, A0673).
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3.2.6. Capillary isoelectric focusing
Capillary isoelectric focusing (IEF) was performed using a BioFocus™ 3000 Capillary
Electrophoresis System (BioRad Laboratories, Hercules, CA, USA). Focusing was
performed in Bio-Lyte Ampholyte (pH 3-10, BioRad), in an eCAP™ neutral capillary
(50 µm x 50 cm, Beckman). BioMark™ CIEF markers (pI values 5.3, 6.4, 7.4, 8.4 and
10.4, BioRad) together with trypsin inhibitor (pI 4.6, Sigma T-1021) were used for internal
calibration. UV detection was at 280 nm.
3.3. Glycosylation analysis
3.3.1. Preparation of glycans
N-glycans of the inhibitors were released by enzymatic hydrolysis with N-glycosidase F.
A dry protein sample (approximately 30 µg) was dissolved in 100 µl of 20 mM sodium
phosphate, pH 7.2, 0.1% SDS, 1% β-octylglycoside and 2 U of N-glycosidase F (Roche
Biochemicals, Switzerland) was added. The reaction mixture was incubated at 37 °C for
48 h and then centrifuged in a ProSpin™ sample preparation cartridge (PerkinElmer
Applied Biosystems Division). The de-N-glycosylated protein was adsorbed to
polyvinylidene difluoride membrane and released N-glycans could be collected from the
flow-trough and further purified from proteins and detergents by passing through a
BondElut C18 extraction cartridge (Varian SPP, Harbor City, CA, USA). The eluted N-
glycan pool was dried and desalted by gel filtration on a Superdex ®Peptide column in
50 mM NH
4
HCO
3
, monitoring at 205 nm and the glycan pool was dried in a vacuum
centrifuge. The amount of N-glycans was estimated by their UV absorbance in gel filtration
chromatography compared with external N-acetylglucosamine and N-acetylneuraminic
acid standards [II].
O-glycans were isolated by subjecting the polyvinylidene difluoride membrane
containing the de-N-glycosylated protein to reductive β-elimination. The membrane was
incubated in 150 µl of 1 M NaBH
4
 in 0.1 M NaOH for 48 h at 37 °C. The reaction was
terminated by adding 5 µl acetic acid to the mixture. Borate was removed by repeated
addition of 1% acetic acid in methanol and evaporation. The O-glycan pool was desalted
by gel filtration as described above [123].
The major glycoproteins of the salmon skin extract were isolated by affinity
chromatography on a 5 x 45 mm column of ConA sepharose (Amersham Pharmacia
Biotech). Samples of skin extract were first run on a Bio-Gel P-6 DG column (10 x 100
mm) in 20 mM Tris/HCl, 250 mM NaCl, 1 mM CaCl2, 1 mM MgCl2 (ConA buffer) to
remove saccharose present in the extract. Then aliquots of 1-3 ml were applied to the
ConA column. Nonbinding proteins were removed by washing with five column volumes
of the ConA buffer, and the N-glycosylated proteins were then eluted with 5 ml of 0.5 M
α-methylmannoside in ConA buffer. Pooled glycoprotein fractions were concentrated
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with pressure microfiltration (Omegacell 10 K) and separated on a C1 reversed phase
chromatography column. This chromatography yielded a major peak carrying two
glycoproteins, 80 kDa and 55 kDa, when analysed on SDS/PAGE. Approximately 40 µg
of total protein was vacuum-dried and subjected to N-glycosidase F treatment and purified
as above.
3.3.2. Permethylation
Dry samples were permethylated by dissolving them in 70 µl NaOH/DMSO suspension.
After 1 h incubation at room temperature, 35 µl methyliodide was added and the mixture
was incubated for 1 h in the dark and vigorously vortexed occasionally [124]. The
permethylated glycans were purified by adsorption to POROS R3 material (Perseptive
Biosystems, Framingham, MA). About 1 µl of POROS material was packed into an
Eppendorf gel-loader tip and washed with water, then the permethylated glycans were
applied to the tip in 20% aqueous methanol. The column was washed with 20 µl of 10%
aqueous methanol and eluted with 5 µl of 50% aqueous methanol.
3.3.3. Removal of O-acetyl groups
O-acetyl groups were removed by mild acidic hydrolysis (saponification) of samples.
Dry samples were dissolved in 0.1 M NaOH and incubated at 8 °C for 80 min. The
reaction was terminated by adding one-half volume of 1 M acetic acid. An aliquot of the
reaction mixture was drop-dialyzed for 30 min against water on VSWP 02500 membranes
(Millipore, Bedford, MA) prior to MALDI-TOF MS analysis.
3.3.4. Periodate oxidation
Saponified N-glycans were incubated in 65 µl of 5 mM NaIO
4
 on ice in the dark for 15
min, and the excess of periodate was destroyed by addition of 10 µl of 0.3 M ethylene
glycol [125]. After 30 min of incubation, 50 µl of 1 M NaBH
4
 in 0.2 M Na
2
CO
3
 was
added and the mixture was incubated at room temperature for 4 hours longer. The reaction
was terminated by adding 2 M acetic acid, and prior to MALDI-TOF MS analysis the N-
glycans were desalted by gel filtration.
3.3.5. Gas-phase β-elimination
Glycopeptide sample was dried in a glass tube, and the tube was placed in a larger glass
tube containing 300 µl of 40% aqueous methylamine [126]. The tube was evacuated until
cool to touch and the sample was allowed to react with methylamine gas for 2.5 h at 55
°C. The deglycosylated peptide was dissolved in 50% aqueous acetonitrile and an aliquot
was analysed in MALDI-TOF MS.
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3.3.6. Exoglycosidase digestions
Digestions with NDV (Newcastle disease virus) neuraminidase and S. pneumoniae β1,4-
galactosidase (Oxford Glycosciences, Abingdon, UK) were carried out in 10 µl of 50
mM sodium acetate, pH 5.5, at 37 °C. Digestion with jack bean β-galactosidase (Glyko,
Novato, CA, USA) was carried out in 10 µl of 100 mM sodium citrate, pH 4.5, at 37 °C.
Aliquots of 1 µl were removed after 16 h of digestion, drop-dialyzed against water, and
analyzed by MALDI-TOF MS.
Pure oligosaccharide standards were used as controls for the glycosidase reactions:
Neu5Acα2,3Galβ1,4(Fucα1,3)GlcNacβOMe for NDV neuraminidase, and
Galβ1,4GlcNAcβ1,6[Galβ1,3GlcNAcβ1,3]Galβ1,4Glc for β1,4-galactosidase.
3.3.7. Mass spectrometry of glycans and glycopeptides
MALDI TOF MS was perfomed on a Biflex™ time-of-flight instrument (Bruker Daltonik,
Bremen, Germany) equipped with a nitrogen laser operating at 337 nm.
Underivatized N-glycans were analysed in either positive ion delayed extraction
reflector mode or negative ion delayed extraction linear mode, using 2,4,6-
trihydroxyacetophenone (Fluka Chemie AG, Buchs, Switzerland) (3 mg/ml in acetonitrile/
20 mM aqueous diammonium citrate, 1:1, by volume) as the matrix as described [127].
Permethylated samples were analysed in the positive ion delayed extraction reflector
mode using 10 mg/ml DHB (Aldrich, Steinheim, Germany) in H
2
O as the matrix.
Peptide samples were analysed using α-cyano-4-hydroxy-cinnamic acid matrix.
3.4. Molecular cloning and sequencing of the inhibitors
3.4.1. Isolation of RNA and DNA
RNA was isolated with QuickPrep™ mRNA purification kit (Amersham Pharmacia
Biotech, Uppsala, Sweden) according to the manufacturer’s instructions or by an
established method [128]. The isolated RNA was reverse transcribed with a Ready-to-go
T-primed First-Strand kit (Amersham Pharmacia Biotech) and the obtained cDNA was
used as a template for polymerase chain reactions. Genomic DNA was isolated with
QIAamp DNA MiniKit (Qiagen, Hilden, Germany) according to the manufacturer’s
instructions.
3.4.2. Primers
All primers were synthesized in DNA synthesis laboratory of Institute of Biotechnology,
University of Helsinki. In the beginning of the study several degenerate primers designed
on the basis of obtained peptide sequences were used before one combination gave a
positive result. Then the primers were designed on the basis of the DNA sequence. All of
the used primers are listed in Table 3.
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3.4.3. Polymerase chain reaction (PCR)
PCR was performed with 20 pmol of two primers, 1 µl of cDNA or genomic DNA, 8 µl
of 1.25 mM dNTP mix, 5 µl buffer and water was added to 50 µl. Enzymes, DyNAzyme
II DNA Polymerase (Finnzymes, Espoo, Finland) or Taq DNa polymerase (MBI Fermentas,
Vilnius, Lithuania) 1 U/50 µl were added either before or after the initial denaturation
step.
Amplification conditions were; initial denaturation 5 min at 95 °C followed by 30
cycles 1 min at 95 °C, 1 min at annealing temperature (see below) and 1 min at 72 °C and
a final extension at 72 °C for 5 min.
Optimal annealing temperature varied between 51-70 °C depending on the primer
pair used. The genomic PCR was done similarly except for a longer elongation time of 90
s and a longer final extension time of 10 min. Obtained PCR products were separated on
1.5% agarose gels, stained with ethidium bromide and visualised under UV light.
3.4.4. Rapid Amplification of cDNA Ends (RACE)
A SMART RACE cDNA amplification kit (Clontech Laboratories, Palo Alto, CA, USA)
utilizes the principle of RACE to obtain full-length cDNA copies of mRNA transcripts
[129]. This kit was used to determine the 5’-end of the salarin gene. A gene specific
Table 3. Sequences and location of primers used in PCR of salarin from Atlantic salmon and
acrtic charr.
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Name Sequence (5’ → 3’) Direction Position in AJ550228
N-term GTNCAYAARGARTTYGARATGAC +
P14r TGRTTCATNCCCATNGTRAA -
SAL1f CTAAAGGACTTTTGCCCATGC + 1545-1564
SAL2f GCTTCAAGATGGGGAGGAAG + 3247-3266
SAL3f GTCTACAATCACAGGGAGAAG + 1-21
SAL4f AATGGATTGGAGAGTTACAC + 1254-1273
SAL5f GAAAGACCTATCCGTCCAC + 3400-3418
SAL1r CATGGTGTAACTCTCCAATC - 1277-1258
SAL2r GAACCTCCTCAGCAGTCAAG - 3706-3687*
SAL3r AAAATAGTTAATTCCTCATAG - 4086-4066
SAL4r TCCATGTTTCAAACTCCTTGTGC - 3296-3274
GSPr1 TCCACCTCTGCTTCCTCCCCTCCATC - 2697-2672
iSALr1 CAAGCTTTCACCTGGATTCA - (intron) 619-599
iSALr2 AGGCCATATTGATATTGATACACT - (intron) 308-285
PolyTN AAGCAGTGGTATCAACGCAGAGTAC(T)30(AGC)
UPM CTAATACGACTCACTATAGGGCAAGCAGTGGTAACAACGCAGAGT
Y= C,T
R= A,G
N= A,C,G,T 
*= mismatch in the 3’ end
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primer (GSPr1, Table 3) was designed on the basis of the sequence already obtained. It
was used together with the UPM primer from the RACE kit. Selected PCR products were
ligated into pCR®2.1-TOPO vector and cloned with TOPO-TA cloning kit (Invitrogen).
The colonies were screened using a direct colony PCR and universal forward (UP) and
reverse (RP) primers [130]. Obtained products were analysed in agarose gel and those
with inserts were used for sequencing.
3.4.5. DNA sequencing of the salarin gene
At least three colonies from the cloned PCR products were sequenced or sequencing was
done directly on the obtained PCR products when applicable. Sequencing was done using
BigDye terminator chemistry and the obtained reactions were analyzed on an ABI 3100
16 capillary sequencer (Applied Biosystems, CA, USA). The obtained sequences were
edited and assembled using the Staden Package programs Trev and Gap [131] on a SUN
workstation. Homology search from the Genebank sequences was performed by the
BLAST program [132]. The obtained salarin sequences were submitted to the EMBL
gene bank with the accession numbers AJ550228 for Atlantic salmon and AJ550229 for
arctic charr.
Materials and Methods
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Figure 4. An overview of the purification method developed for the high molecular weight cysteine
proteinase inhibitors from the skin of fish.
Results
4. RESULTS
4.1. Purification of cysteine proteinase inhibitors from fish skin
All cysteine proteinase inhibitors were purified following a similar four-step scheme:
papain affinity chromatography, gel f iltration chromatography, anion-exchange
chromatography and finally reversed phase chromatography. This method was developed
for purification of cysteine proteinase inhibitors from the skin of Atlantic salmon in
study (I). An overview of this purification is presented in Figure 4.
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The first step in purification of cysteine proteinase inhibitors from the fish skin
extract was affinity chromatography on immobilized papain. The proteins bound to papain-
Sepharose were eluted and the fractions showing inhibitory activities over 70% were
pooled, concentrated and further purified by gel filtration. The fractions from gel filtration
exhibiting inhibitory activity were subjected to anion-exchange chromatography. With
salmon skin extract the inhibitory activity was separated into two main fractions by anion-
exchange chromatography. In further fractionation by reversed-phase chromatography
salmon skin contained two cysteine proteinase inhibitors (I and II), which in SDS-PAGE
migrated at positions relative to apparent molecular weights of 43 kDa and 76 kDa.
In contrast to the salmon skin only one fraction with inhibitory activity was obtained from cod
skin extract on anion exchange chromatography. This fraction was further purified by reversed
phase chromatography after which the main protein migrated in SDS-PAGE relative to apparent
molecular weight of 78 kDa. Similarly treated wolf fish skin extract also gave one fraction with
inhibitory activity in anion exchange chromatography, and after purification the major protein in this
fraction showed an apparent molecular weight of 67 kDa in SDS-PAGE. These four proteins with
cysteine proteinase inhibitory activity were further characterized.
4.2. Characterization of the inhibitors
4.2.1. Chemical and physical properties
The exact molecular masses of the purified inhibitors were determined by MALDI TOF
mass spectrometry where the salmon inhibitor I gave a molecular mass of 42.7 kDa and
salmon inhibitor II,  a molecular mass of  51.8 kDa. In similar analysis cod inhibitor gave
a molecular mass of 51.0 kDa and wolf fish inhibitor a molecular mass of 45.8 kDa.
From the differences between SDS/PAGE and mass spectrometry we suspected that these
proteins were glycosylated, this was later confirmed (see below). The isoelectric points
of the purified inhibitors were determined by capillary isoelectric focusing. Salmon
inhibitor I had a pI 5.1 and salmon inhibitor II has pI’s 4.0, 4.2. and 4.6. Also, cod and
wolf fish inhibitors had several isoelectric points (pI’s 3.6, 3.9 and 4.4 for cod inhibitor
and pI’s 4.1, 4.3, 4.35 and 4.4 for wolf fish inhibitor). The obtained molecular masses,
isoelectric points as well as other properties of the inhibitors are summarized in Table 4.
Results
Table 4. A summary of the properties of the purified fish inhibitors (n.d. = not determined)
              Molecular weight (kDa) by
Fish         Inhibitor SDS/PAGE and MALDI-TOF MS        pI specific inhibition
________________________________________________________________________________________
Atlantic salmon     salarin 43 42.7         5.1 2900 U/mg
Atlantic salmon kininogen 76 51.8 4.0, 4.2, 4.6 2250 U/mg
Atlantic cod kininogen 78 51.0      3.6, 3.9, 4.4 940 U/mg
spotted wolf fish kininogen 67 45.8 4.1, 4.3, 4.35, 4.4 6200 U/mg
arctic charr salarin 43 43.2         n.d. n.d.
arctic charr kininogen 75 n.d. n.d. n.d.
rainbow trout salarin 43 43.6 n.d. n.d.
rainbow trout kininogen 78 51.2         n.d. n.d.
turbot         kininogen 78 n.d.         n.d. n.d.
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4.2.2. Protein sequencing
All the purified inhibitors were subjected to N-terminal sequencing as well as enzymatic
digestions followed by peptide separation and N-terminal sequencing of the peptides.
The kininogens were also compared by peptide mass fingerprinting. All obtained sequences
are presented in Table 5.
To investigate the possible homology of these inhibitors to other known proteins the
obtained peptide sequences were compared with proteins in databanks. It was shown that
salmon inhibitor I had a low similarity with some cysteine proteinases but it had no close
match with any previously known protein so we named it salarin. Salmon inhibitor II had
peptide sequences matching with kininogens, so we named it salmon kininogen. Cod and
wolf fish inhibitors had sequences matching with kininogens too so we named them cod
kininogen and wolf fish kininogen, respectively. The peptide sequences of the three
kininogens are aligned with human kininogen in Fig 5.
Figure 5. Comparison of amino acid sequences of kininogens.  The determined peptide sequences
from salmon kininogen (2 SAL KIN), cod kininogen (3 COD KIN) and wolffish kininogen (4
WF KIN) are aligned with the heavy chain of human kininogen (1 KNH_HUMAN) sequence.
1 KNH_HUMAN MKLITILFLC SRLLLSLTQE SQSEEIDCND KDLFKAVDAA LKKYNSQNQS
2 SAL KIN ELE PEQVLAFCDD KDVEAAVFLA LVKYN  LPY
3 COD KIN RHE VPQANLECDE GAMDLK            IST
4 WF KIN XLV QPGVLIFCDD PS            YNSMSDS
1 KNH_HUMAN NNQFVLYRIT EATKTVGSDT FYSFKYEIKE GDCPVQSGKT WQDCEYKDAA
2 SAL KIN GNQLALYQIL ESSK                           V WRDCDYLPTG
3 COD KIN GNMVALYQIL SASK                D SDCPAGGAVT WTD
4 WF KIN THLFTLHFVX Y  SENGSDS VYSLQFTSR  SDCPAGSNKP WTECDYLSYE
1 KNH_HUMAN KAATGECTAT VGKRSSTKFS VATQTCQITP AEGPVVTAQY DCLGCVHPIS
2 SAL KIN NK     VLAVFCDP VEAPVVAERT TCLGCPREID
3 COD KIN
4 WF KIN RR
1 KNH_HUMAN TQSPDLEPIL RHGIQYFNNN TQHSSLFMLN EVKRAQRQVV AGLNFRITYS
2 SAL KIN VEG    DPL TYSITRFNAD SDSSHHFILN
3 COD KIN                                   QVV AGLR
4 WF KIN            FNER LSTGHK
1 KNH_HUMAN IVQTNCSKEN FLFLTPDCKS LWNGDTGECT DNAYIDIQLR IASFSQNCDI
2 SAL KIN XFVP LTVLEPGQEK
3 COD KIN
4 WF KIN                                              QVY 
1 KNH_HUMAN YPGKDFVQPP TKICVGCPRD IPTNSPELEE TLTHTITKLN AENNATFYFK
2 SAL KIN
3 COD KIN        ICMGCPVE LDLESEELKV PVAVSISK
4 WF KIN CLLDDVIIPE KAPCLGCPME VDENSEDLKF PLSVSISK
1 KNH_HUMAN IDNVKKARVQ VVAGKKYFID FVARETTCSK ESNEELTESC ETKKLGQSLD
2 SAL KIN ELNDEC HPDPDVELAH
3 COD KIN
4 WF KIN
1 KNH_HUMAN CNAEVYVVPW EKKIYPTVNC QPLGMISLMK RPPGFSPFR
2 SAL KIN CNSTVDVAPW R    RPPGWSPLR
2 COD KIN  R RPPGWSPLR 
3 WF KIN               A GALPTMFTRR RPPGWSPLR
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Table 5a. N-terminal and peptide sequences determined from salarin. X = not identified amino acid.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
N-terminal K P L P E D S E A G V H K E F E M T K V K Y G K X Y P
1 L M V V F P X R D G G E E A E V D K E F E T W K
2 G L L P M P R P E E E E V D K E F E M W K
3 T T A E V T G R R L Q F G E E A E V H K
4 T T A E V T G R R L Q D G E E A E V H K
5 T Y P S T V E E A K
6 S Y P S T E E E A K
7 E M W L A T R K
8 E I W L A T R K
9 M V M E H N K R
10 V M E H N T R A G N G L E S Y T M A V N H L A D T
11 A G N G L E S Y T M A V N H L A D L T T E E V P K
12 A E X G S E S F T M G I N Y F S D M T Q E E I P K
13 A E N G L E S F T M G V N H F A D L T A E E V P R
14 R A E T G S E S F T M G M N H L S D K
Table 5b. N-terminal and peptide sequences determined from salmon kininogen.  X = not identified amino acid.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
N-terminal no result
1 V P R P C K
2 A T V H M S E T D K
3 V W R D C D Y L P T G N K
4 L P Y G N Q L A L Y Q I L E S S K
5 E L N D E C H P D P D V E L A H C N S T V D V A P W R
6 E L N D E C H P D P D V E L A H C X S T V D V A P W R
7 D P L T Y S I T R F N A D S D S S H H F I L N
8 E L E P E Q V L A F C D D K D V E A A V D L A L V K
9 V L A V F C D P V E A P V V A E R T T C L G C P R E I D V E G
10 C D P V E A P V V A E R T T C L G C P R E I D V V
11 A Q X D S C T Q Y F V E F N S R
12 X F V P L T V L E P G Q E K
13 H E T A E A N V E C A P G P L D N F D V F R
14 C A P G P L D N F P V F R R R P P
15 R R P P G W S P L R
Table 5c. N-terminal and peptide sequences determined from cod kininogen.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
N-terminal no result
1 A A V T S F N E K
2 E F S P P A P P S R
3 H E V P Q A N L E C D E G A M D L K
4 R R P P G W S P L R
5 I C M G C P V E L D L E S E E L K V P V A V S I S K
6 I S T G N M V A L Y Q I L S A S K
7 Q V V A G L R
8 D S D C P A G G A V T W T D
9 Y S L Y F D M R K
Table 5d. N-terminal and peptide sequences determined from wolf fish kininogen.  X = not identified amino acid.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
N-terminal no result
1 X L V Q P G V L I F C D D P S
2 K A P C L G C P M E V D E N S E D L K
3 Q V Y C L L D D V I I P E K
4 R K K P I S C N A T V Y M T E T E A D T K
5 A G A L P T M F T R R R P P G W S P L R
6 S E X G S D S V Y S L Q F T S R
7 Q V Y C L L D D V I I P E K
8 D L N D L C V P D D Q N A G Y A N C X S T V N V A
9 S D C P A G S N K P W T E C D Y L S Y E R R
10 Y N S M S D S T H L F T L H F V X Y
11 F N E R L S T G H K
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4.2.3. Functional properties
The inhibitory activity of purified inhibitors was determined against papain, ficin,
bromelain and trypsin by inhibition assay. All inhibitors were found to inhibit papain and
ficin (Fig 6.) but had no effect on trypsin (serine proteinase) and very weak effect on
bromelain (inhibition of 0-20%). The specific activities against papain were calculated
from the inhibition curves and are presented in Table 4.
Results
Figure 6. The inhibitory activities of purified cysteine proteinase inhibitors from fish skin.
Inhibition of 0.25 µg of papain by different amounts of A) salarin, B) salmon kininogen, C) cod
kininogen and D) wolf fish kininogen.
26
4.3. Analysis of glycan structures
Glycosylation of inhibitors was suspected from the difference between molecular weight
determined by SDS/PAGE and by MALDI TOF mass spectrometry (Table 4) and it was
confirmed by digestion with N-glycosidase F. To release N-glycans for more detailed
characterization all inhibitors were treated with N-glycosidase F.
Approximately 1 nmol of N-glycans were released from 0.6 nmol of salmon kininogen,
thus implying two N-glycosylation sites. The MALDI TOF spectrum of salmon kininogen
N-glycans showed three clusters of ions with intervals of 42 Da (Fig 7A). This implied
Results
Figure 7. MALDI-TOF spectra of N-glycans isolated from inhibitors. A) Intact glycans from
salmon kininogen. B) Salmon kininogen N-glycans after saponification. C) Intact glycans from
cod kininogen. D) Cod kininogen N-glycans after saponification. E) Intact glycans from wolf
fish kininogen. F) Wolf fish kininogen glycans after saponification. The proposed glycan structures
are shown:   , N-acetylglucosamine,    , mannose,    , galactose,   , N-acetylneuraminic acid,
circled S, sulphate. All spectra were recorded in linear negative ion mode, signals are [M-H]-
ions and average mass values are shown.
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variable degree of acetylation in the glycan structures, most probably O-acetylation of
sialic acids [133].When relative intensities of the signals are used to the estimate molar
ratio of the components [134], about 60% of sialic acids seem to be di-O-acetylated.
The tentative N-glycan structure was verified by removal of O-acetylation by short
alkaline hydrolysis (saponification) [135] and subsequent digestions of saponified glycans
with Newcastle disease virus (NDV) neuraminidase (specific only to α 2,3- and α 2,8-
linked sialic acids) and with S. pneumoniae β1,4-galactosidase (specific only to β1,4-
galactose). After saponification the MALDI TOF MS spectrum showed one major signal
(m/z 2223.1 [M-H]-) appropriate for disialylated biantennary N-glycan. The glycan
structure is drawn in Fig 7B. Trisialylated N-glycan is also observed in this spectrum (m/z
2514.3 [M-H]-). When permethylated trisialylated N-glycans were analyzed with ESI
MS they were shown to have a disialosyl (α2,8) group.
A sample of salarin (30 µg, approx. 0.7 nmol) was treated by the same methods as
above, yielding 0.5 nmol of N-glycans which indicated there was only one N-glycosylation
site. When the above mentioned structural studies were performed the results were
practically identical with salmon kininogen N-glycans.
A MALDI TOF MS spectrum of isolated Atlantic cod N-glycans revealed two major
clusters with adducts of + 42 and +80 Da, so in addition to probable acetylation observed
in salmon inhibitors there was another adduct, possibly phosphorylation or sulfation (Fig
7C). Alkaline phosphatase treatment did not remove the +80 Da adduct so it was presumed
to be a sulphate (SO
3
) group.
After saponification and subsequent digestions with NDV sialidase, S. pneumoniae
β1,4-galactosidase (known to be unable to hydrolyze galactose from Galβ1-4GlcNAc-R
type structures where either Gal or GlcNAc is sulphated [136]) and with jack bean β-
galactosidase (inhibited by sulphate on Gal unit only) the cod N-glycan structures were
verified as bi- and triantennary N-glycans terminated by highly O-acetylated α2,3-sialic
acids. About 1/3 of the glycans carried sulphate at GlcNAc. The structures are presented
at Fig 7D.
The isolated N-glycans of the wolf fish kininogen exhibited a similar complicated
pattern in MALDI-TOF MS (Fig. 7E), with two major clusters of ions. Adducts of + 42
Da are again evident in the spectrum, implying extensive O-acetylation of sialic acids but
no adducts of +80 Da are observed. Again the subsequent saponification and digestions
with NDV sialidase and S. pneumoniae β1,4-galactosidase confirmed the N-glycan
structures of wolf fish kininogen as α 2,3-sialylated bi- and triantennary N-glycans, with
extensive sialic acid O-acetylation (Fig 7F).
Two glycopeptides were isolated from both salmon kininogen and salarin and their
amino acid sequences were determined. N-terminal sequencing of the salmon kininogen
glycopeptides showed that both peptides had N-glycosylation sites (Appendix B. Table
1b.). One glycopeptide of salarin was stable against N-glycosidase F treatment thus
implying O-glycosylation which was confirmed by N-terminal sequencing (Appendix B
Table 1a)
O-glycosidically bound glycans in salmon kininogen and salarin were liberated by
alkaline reductive β-elimination. The isolated, permethylated O-glycans from both
Results
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inhibitors yielded a MALDI TOF spectrum suggesting a composition
(Neu5Ac)
2
(Hex)
1
(HexNAc-ol)
1,
a disialylated core type-1 O-glycan (Figure 8). With
fragmentation analysis by MS/MS it was shown that two sialic acids do not form a
diNeu5Ac unit as in N-glycans.
O-glycosidic glycans were also recovered from cod and wolffish kininogen. The
permethylated O-glycan pool was analyzed by MALDI-TOF MS, and the spectrum
revealed the same major [M+Na]+ signal at m/z 1256.63 matching with O-glycan structure
in salmon kininogen and salarin.
Two major glycoproteins from salmon skin were isolated and their N-glycan structures
were isolated by a similar method and analyzed by MALDI TOF MS. Their glycan
spectrum was very similar to those obtained from salmon kininogen and salarin, indicating
that extensive O-acetylation of sialic acids is also found in other glycoproteins than
inhibitors.
4.4. Cysteine proteinase inhibitors in other fish species
Since salarin was found only in Atlantic salmon but not in cod or wolf fish the question
about its existence in other fish species arose. Thus the skin extracts of a few other fish
species were investigated using the purification method developed for the salmon
inhibitors. The skin extract of Arctic charr was treated by the same method as above. In
anion exchange chromatography the inhibitory activity was separated into two main
fractions which were then further purified by reversed phase chromatography. When
they were analysed by SDS/PAGE they migrated to positions according to molecular
weights of 43 kDa and 70 kDa. When the purified proteins were N-terminally sequenced
the N-terminus of 43 kDa protein was identical with salarin and the N-terminus of 70
kDa protein was blocked. The proteins were then enzymatically digested and a peptide
mass fingerprint was obtained thus confirming them to be charr salarin and charr
kininogen.
Rainbow trout skin extract was treated similarly and it yielded two inhibitors with
molecular masses of 43.5 kDa and 51.2 kDa. The N-terminus of the 43 kDa protein was
identical to that of salarin. In SDS/PAGE and in MALDI TOF mass spectrometry the
salarin also showed a smaller fragment of 34.8 kDa which had an identical N-terminus.
When the skin extract of turbot was analysed with a similar method it produced only
one inhibitor with an apparent molecular weight of 70 kDa. It was presumed to be a
kininogen, but no further experiments were performed to verify this assumption.
These results are summarized in Table 4.
Results
Figure 8. A proposed structure for O-glycan in
salmon kininogen, disialylated core 1 type O-
glycan.
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4.5. Molecular cloning and sequencing of the salarin cDNA
Salarin cDNA sequence was obtained from salmon liver by RT-PCR with degenerate
primers which were designed on the basis of the peptide sequences. Several degenerate
primer pairs were tried before two degenerate primers, N-term and P14r (Table 3)
corresponding to the N-terminus and peptide P14 of salarin (Table 5a), yielded a successful
product. After this first salarin DNA stretch was sequenced it was possible to design gene
specific primers for PCR and thus obtain the whole salarin coding sequence of 1026 bp.
The predicted amino acid sequence of salarin has a putative 19 amino acid signal sequence
and a 323 amino acid mature protein. The protein sequence consists of four almost identical
domains differing by only a few amino acids (Fig. 9). The previously obtained peptide
sequences matched almost precisely with the predicted amino acid sequence.
Results
Figure 9. The translated amino acid sequences of salarin from Atlantic salmon (line 1) and arctic
charr (line 2). Repeated amino acid sequences are outlined in square box. The N-glycosylation
site is marked with  and the O-glycosylation site is marked with . Black triangles show intron
sites. Stars denote identical amino acids in all four domains of salmon salarin. Underneath the
stars is depicted the cathepsin L –proregion motifs ERFNIN and GNDF with modifications.
Also phytocystatin motif LARFAVDEHN can also be found in the salarin sequence.
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PCR using cDNA made from salmon skin as template did not result in any products.
This suggests that salarin is not transcribed in skin but transported there.
With the charr liver cDNA as a template for PCR the salmon salarin primers resulted
in similar products as in salmon. The charr gene has an identical signal sequence with the
salmon gene and the amino acid sequence has the same four domains and only 19 amino
acids differ from the salmon protein (Fig. 9).
We also isolated RNA from the liver of spotted wolf fish and made cDNA from it.
PCR amplifications with the primer pairs SAL 1f +SAL 2r and SAL 3f +SAL1r were
negative. This confirmed our previous negative result for the obtained protein data from
wolf fish.
Genomic DNA was isolated from Atlantic salmon liver. To evaluate possible introns
in the gene different primer combinations were tried in PCR to amplify the genomic
sequence. The products were sequenced and combined thus yielding a complete salmon
salarin gene. The salarin gene altogether contained 12 introns. All the intron borders
followed the rule GT/AG except for the last intron (#12) which was GT/CA. It is interesting
that intron 1 is located only 15 bp from the ATG start codon and contains two GT repeats
and the last exon (13) contains only one amino acid from the coding gene. Allelic variation
in the GT repeat was detected as part of the clones contained variable length GT.
Furthermore, two different sequences were obtained differing by five bases in intron 11
indicating allelic variation in intron length.
A picture of the salarin gene structure is presented in Fig. 10.
Results
Figure 10. A schematic picture of the salarin gene. Primers are shown with arrows numbered
according to Table 3. Boxes indicate exons, white boxes UTRs and black boxes coding areas.
Introns are marked with # and a running number.
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5. DISCUSSION
5.1. Cysteine proteinase inhibitors from fish skin
In this study four high molecular weight cysteine proteinase inhibitors from three different
fish species were purified and characterized. Further, five similar inhibitors were shown
to exist in three other fish species. Three of the purified inhibitors were kininogens which
have not been isolated from any fish species prior to these studies. Kininogens were
found from all six fish species studied. The fourth of the purified inhibitors was named
salarin, this was found only in salmonid species.
All three kininogens were N-terminally blocked and a smaller fragment with open
N-terminus copurified with the full size protein. The smaller fragment might be a
differentially processed form of kininogen. Most of the peptide sequences obtained from
fish kininogens matched with the human kininogen heavy chain which is conserved among
different kininogens (Fig. 5a). Those peptides which did not match with the kininogen
heavy chain may originate from the light chain or represent a more variable region in the
heavy chain. Bradykinin peptide was found from each fish kininogen thus fortifying
their identification. The fish bradykinin sequence differed from that of human one by
two amino acids (Fig 5B).
All kininogens inhibited cysteine proteinases like papain and ficin but their specific
inhibitory activities against papain varied from 940 U/mg of cod kininogen to 6200 U/
mg of wolf fish kininogen, where U is defined as µg of papain inhibited per mg of
inhibitor (Table 3). Interestingly, salmon cathepsin B was not at all inhibited by kininogens
at test levels of 76 nM salmon kininogen and 300 nM wolf fish kininogen. On the other
hand, cathepsin L from cod, salmon and wolf fish were inhibited by salmon kininogen
and wolf fish kininogen (Dr. Ekkehard Weber, personal communication). The inhibition
of cathepsin B by cystatins is reported to be weaker than that of papain or cathepsins H
and L [51].
The antibacterial effects of kininogens and salarin were studied by comparing the
inhibition zones around filter discs immersed into inhibitor solution and then placed
onto the bacteria plate [42]. The antiviral effects were studied by fish cell cultures grown
with inhibitors and then inoculated with viruses [42]. It has been shown that low molecular
weight cystatins are able to inhibit the growth of bacteria [137]. In contrast to previous
reports, the inhibitors had no effect on viral or bacterial growth in this study. However, it
is possible that the inhibitors studied here are too large to act as antibiotics in these
assays. Kininogens and salarin did not inhibit a virus-induced apoptosis in fish cell lines
either [138]. Again, one reason for the negative results may be the size of kininogens and
salarin as 11 kDa acid cysteine proteinase inhibitor (ACPI) is reported to inhibit
rhabdovirus induced apoptosis in fish cell line [139]. It is also possible that the protective
mechanism of high molecular weight inhibitors is mediated inhibiting the penetrative
action of bacterial proteinases rather than inhibiting the bacterial growth on the whole.
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5.2. Salarin
Salarin from Atlantic salmon is a 42.7 kDa glycoprotein which has four similar domains.
A 30 kDa fragment with identical N-terminus copurified with the 42.7 kDa protein.
Salarins theoretical mass calculated from the amino acid sequence is 37.5 kDa thus leaving
5.2 kDa for glycans which appears reasonable. When compared with other known cysteine
proteinase inhibitors salarin has very little structural similarity. However, phytocystatins
have a LARFAVDEHN motif [55] which is partially present in salarin (Fig 9.). As this
motif is not found in other cystatins, it can not be essential to their inhibitory activity.
Proregions of cathepsin L –like proteinases have an interspersed ERFNIN –motif
which is found in  salarin too. Also, a short conserved sequence GNFD from cathepsin
proregion [11] is present in the salarin sequence (Fig. 9). One function of the cathepsin
proregion is to inhibit the proteolytic activity of cathepsin before entering the correct
subcellular compartment [9]. Autonomous proregion -like inhibitors are also known [77].
A database search with salarin sequence results in one close match, AF281331, a
115 amino acid cathepsin from rainbow trout (O. mykiss). This sequence was identified
by the closest hit from a BLAST search and no other tests were performed [36]. It is
possible that the similarity was observed on the proregion of cathepsins, thus misguiding
the authors to think that they had sequenced a cathepsin when they actually had sequenced
a cathepsin L proregion-like inhibitor.
This idea is also supported by the fact that salarin effectively inhibited cathepsin L
from salmon, cod and wolf fish but it had only little effect on cathepsin H and no effect
on cathepsin B of salmon (Weber, personal communication). As cathepsin proregions are
known to inhibit most effectively their cognate enzymes it is very likely that salarin is a
cathepsin L proregion -like cysteine proteinase inhibitor.
The appearance of salarin in our studies was limited only to salmonid species, this
was unexpected. It may be that the size of salarin has decreased during evolution, although
then it should have been found also from wolf fish cDNA.  However, the existence of a
salmonid specific cysteine proteinase inhibitor appears quite unlikely.
Equally surprising was the number of introns in the salarin gene. The sequencing of
the complete genome of pufferfish (Fugu rubribes), the first fish genome, was recently
reported [140]. Compared to the human genome it is only one-ninth of size, but contains
the same amount of genes.  The pufferfish genome has shorter introns and a smaller
amount of repetitive DNA [141]. Comparison of the salarin sequence against zebrafish
genome resources (NCBI) identifies cathepsin L as a highly similar sequence.
5.3. Glycosylation of cysteine proteinase inhibitors
We isolated and characterized the glycan structures from the purified cysteine proteinase
inhibitors. The salmon kininogen and salarin were shown to have biantennary N-glycans
with mono-, di- or tri-O-acetylated α2,3-linked sialic acids. Trisialylated N-glycan carries
an α2,8-disialosyl group with up to four O-acetyl groups. The O-glycans from salmon
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kininogen and salarin were mostly disialylated type-1 core glycan with no indication of a
disialosyl group (Fig. 8).
Wolf fish kininogen carries an α2,3-sialylated biantennary and triantennary N-glycans
and disialylated core type-1 O-glycans. Cod kininogen similarly carries O-acetylated
α2,3-sialylated biantennary and triantennary N-glycans but about 1/3 of them are sulphated
at their antennal N-acetylglucosamine units. Also the cod kininogen O-glycan had a type-
1 core with two sialic acids.
We also studied the major N-glycoproteins, transferrin and an unidentified 55 kDa
glycoprotein, from the skin of Atlantic salmon. Their glycosylation was very similar to
that of salmon kininogen and salarin with a high degree of O-acetylation.
O-acetylation of sialic acids has been described before in f ish. The
polysialoglycoprotein from the unfertilized eggs of the kokanee salmon (Oncorhynchus
nerka adonis) contains N-glycolylneuraminic acid (Neu5Gc) with 4-, 7- and 9-O-
acetylation and 9-O-acetylated ketodeoxynononic acid (KDN) [107].
These glycan structures, sialylated biantennary and triantennary N-glycans, are
common vertebrate glycans. The high amount of O-acetylation in sialic acids was however
unexpected. Practically all terminal sialic acid residues were O-acetylated. To the best of
our knowledge, these represent by far the most extensively O-acetylated N-glycans
characterized from any species to date. One reason for the scarce reports of O-acetylation
might be that they are easily destroyed by standard glycan isolation procedures [142].
O-acetylated polysialic acid chains are resistant to bacterial sialidases specific for
hydrolysing this kind of α2,3-linkages [107]. The same phenomenon is also observed in
O-acetylated sialoglycoproteins [135]. Albeit, the biological function of O-acetylation is
not fully understood, it has been proposed that is serves as a protective agent, as O-
acetylation inhibits the binding of several pathogens like influenza A and B viruses [143]
or malarial parasites to murine erythrocytes [144].  O-acetylation in the colon appears in
response to microbial colonization [145] and the intestinal level of O-acetylation varies
with the amount of microbes [146]. In addition, O-acetylated sialic acids are detected in
neural gangliosides where they have a role in the development of certain organs [147].
One function of O-acetylation is to provide a primary barrier for host cells and tissues
against attacking pathogens. Therefore, it is quite natural that this kind of protective
modification is observed in unfertilized eggs of salmon which are usually laid in the
bottom of rivers whose waters are full of micro-organisms. On the other hand, the skin of
fish is also a barrier against pathogens so in this context our finding of extensive O-
acetylation could have been expected.
In salmon kininogen we demonstrated a Neu5Acα2,8-Neu5Ac disialosyl group from
N-glycans.
An α2,8-sialyltransferase has been described from the eggs of rainbow trout
(Oncorhynchus mykiss) [148]. Later also an α2,8-disialylated N-glycan was reported
from rainbow trout ovarian fluid [110]. Disialosyl groups were first described from the
rat brain in 1977 [104, 105].
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Cod kininogen carries a sulphate group in its antennal N-acetylglucosamine.  The
most well-known sulphated glycans are chondroitin sulphate and heparan sulphate [99]
but sulphated glycans have been described on glycoproteins like HIV gp120 [149],
respiratory mucins [150], thyroglobulin [151] and hen egg albumin [152]. Sulphated
glycoproteins have also been detected from fish; the eggs of dace have highly sulphated
multiantennary N-glycans [109]. The biological significance of sulphation is not fully
understood but sulphation modifies glycoconjugates to a more acidic and viscose direction
[150], increase structural diversity for recognition and signalling purposes. As other
kininogens were not sulphated this explanation however is not convincing for the sulphation
of cod kininogen. Sulphation is also known to increase protease resistance, water-holding
capacity and high charge density and it is often associated with sialylation and O-
acetylation [153]. Cod live at the bottom of the sea [37] and therefore it is possible that
sulphation in cod skin kininogen is just adding protection for the fish living in this
hazardous environment.
We detected only Neu5Ac as sialic acid species in fish skin glycoproteins and no
evidence of Neu5Gc or KDN was seen. This is slightly surprising as several fish eggs are
reported to have both NeuGc and KDN [107], with or without O-acetylation [154]. This
might be a sign of the different function of different sialic acids or perhaps targeting of
glycoproteins is mediated by different types of sialic acids.
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6. CONCLUSIONS
Four cysteine proteinase inhibitors with interesting characteristics were found. Kininogens
were found in all fish species studied. Salarin is a new type of cysteine proteinase inhibitor
and it was cloned. As salarin is a new type of inhibitor it will be interesting to see whether
salarin is found in other fish and animal species. Salarin belongs to a new family of
cysteine proteinase inhibitors, proregion-like cysteine proteinase inhibitors, but further
studies are needed to characterize its specificity in detail. It also remains to be seen
whether salarin is a salmonid specific inhibitor.
In this study, the analyzed glycans were isolated from the fish skin. Structural analysis
of the glycans isolated from inner organs of the studied fish is needed to see whether the
unusually high O-acetylation found is a characteristic of fish skin.
Although the original suggestion that high molecular weight cysteine proteinase
inhibitors from the skin of fish could be defensive agents against viruses, bacteria and
pathogens, could not be confirmed, it is possible that in tests more suitable for large
molecules the effect of these inhibitors could be seen. As these inhibitors are transported
to skin and they have glycan structures of a protective type it is very likely that they act as
defensive agents in some yet undefined way.
It has been fascinating to realize that proteinases and their inhibitors are on opposite
sides but they still work together to keep up nature’s balance.
Conclusions
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